APA (7th ed.) Citation

RK, W., & IC, L. (2026). Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer-Reassurance With Vigilance. Alimentary pharmacology & therapeutics, 63(3), 433. https://doi.org/10.1111/apt.70388

Chicago Style (17th ed.) Citation

RK, Wu, and Lee IC. "Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer-Reassurance With Vigilance." Alimentary Pharmacology & Therapeutics 63, no. 3 (2026): 433. https://doi.org/10.1111/apt.70388.

MLA (9th ed.) Citation

RK, Wu, and Lee IC. "Editorial: Immune Checkpoint Inhibitors and HBV Reactivation in Liver Cancer-Reassurance With Vigilance." Alimentary Pharmacology & Therapeutics, vol. 63, no. 3, 2026, p. 433, https://doi.org/10.1111/apt.70388.